scholarly journals Clinical presentation and non-invasive diagnosis of right heart masses.

Heart ◽  
1981 ◽  
Vol 46 (5) ◽  
pp. 552-558 ◽  
Author(s):  
M J Stern ◽  
M V Cohen ◽  
B Fish ◽  
R Rosenthal
Keyword(s):  
Clinical Presentation ◽  
Right Heart ◽  
Non Invasive

scholarly journals Hepatic Venous Duplex as an Alternative Non- invasive Diagnostic Tool for Diagnosis of Pulmonary Hypertension

2020 ◽  
Vol 16 (2) ◽  
pp. 86-91
Author(s):  
Md Harisul Hoque ◽  
SM Mustafa Zaman ◽  
Khurshid Ahmed ◽  
Sajal Krisna Banerjee ◽  
Md Faisal Ibne Kabir ◽  
...  
Keyword(s):  
Pulmonary Hypertension ◽  
Diagnostic Tool ◽  
Right Heart Catheterization ◽  
Diagnostic Methods ◽  
Heart Catheterization ◽  
Right Heart ◽  
Non Invasive ◽  
Close Proximity ◽  
The Right ◽  
Practical Demonstration

Pulmonary hypertension is a hemodynamic disorder defined by abnormally high pulmonary artery pressure that affects the arteries in your lungs and the right side of your heart. In this study, hepatic venous duplex will be done to diagnose and quantify the PH. So that Patients can avoid unnecessary invasive right heart catheterization. This practical demonstration is the key to enrich our experience and knowledge in the field of PH. Objectives of this study was to assess PH status by Hepatic venous Duplex (HVD) as well by right heart catheterization and to compare them. This study was conducted in the Department of Cardiology, BSMMU, Shahbagh, Dhaka extending from July 2018 to December 2019. Total 100 (One hundred) subjects were enrolled in this study. It was an Observational study and includes the subjects between 18 years to 45 years of age. Results of this study shows very close proximity to that of Right heart catheterization. Hemodynamic changes in Hepatic venous duplex study could be used as an alternative diagnostic tool for evaluating moderate to severe pulmonary hypertension. This method could counteract the weakness of the currently used diagnostic methods and improve the accuracy of assessing pulmonary hypertension when combined with other methods. University Heart Journal Vol. 16, No. 2, Jul 2020; 86-91

scholarly journals A Rare Clinical Presentation Caused by Atrial Myxoma: Right Heart Failure

2021 ◽  
Vol 2 (1) ◽  
pp. 65-68
Author(s):  
Ferhat Dindaş ◽  
İdris Buğre Cerik ◽  
Emin Koyun ◽  
Okan Onur Turgut
Keyword(s):  
Heart Failure ◽  
Clinical Presentation ◽  
Right Heart Failure ◽  
Atrial Myxoma ◽  
Right Heart

Cardiac catheterization

2020 ◽  
pp. 71-105
Author(s):  
Andrew Mitchell ◽  
Giovanni Luigi De Maria ◽  
Adrian Banning
Keyword(s):  
Cardiac Catheterization ◽  
Right Heart Catheterization ◽  
Heart Catheterization ◽  
Pressure Measurements ◽  
Right Heart ◽  
Non Invasive ◽  
Contrast Angiography ◽  
Doppler Techniques ◽  
Left And Right ◽  
Anatomical Information

Cardiac catheterization allows the invasive acquisition of haemodynamic data using direct and indirect pressure measurements and oxygen saturations, and provides anatomical information using contrast angiography. Right heart catheterization used to be a routine part of an invasive cardiac study. The increased accessibility and accuracy of non-invasive imaging (in particular, echocardiography and Doppler techniques), however, has reduced the need to perform right heart catheterization. This chapter describes the principal uses of cardiac catheterization, the basics of pressure waveforms, equipment required, accessing the left and right heart, left and right heart pressures and waveforms, how to perform calculations, and the techniques of ventriculography and aortography.

P2774Galectin-3, GDF-15, and ST2 in noninvasive assessment of myocardial remodelling in chronic thromboembolic pulmonary hypertension

2019 ◽  
Vol 40 (Supplement_1) ◽  
Author(s):  
S D Kriechbaum ◽  
K Peters ◽  
R Ajnwojner ◽  
J S Wolter ◽  
M Haas ◽  
...  
Keyword(s):  
Pulmonary Hypertension ◽  
Pulmonary Artery ◽  
Disease Severity ◽  
Chronic Thromboembolic Pulmonary Hypertension ◽  
Control Group ◽  
Right Heart ◽  
Non Invasive ◽  
Galectin 3 ◽  
Myocardial Remodelling ◽  
Thromboembolic Pulmonary Hypertension

Abstract Background In chronic thromboembolic pulmonary hypertension (CTEPH), pulmonary artery obstruction leads to impaired pulmonary hemodynamics and secondary right heart failure, which is highly predictive of outcome. Thus, the extent of myocardial -especially right heart- remodelling is an indicator of disease severity. Purpose The aim of the present study was to assess growth differentiation factor-15 (GDF-15), galectin-3, and suppression of tumorigenicity 2 (ST2) as non-invasive biomarkers of myocardial remodelling in patients suffering from CTEPH. Methods We analysed the serum levels of GDF-15, galectin-3 and ST2 in a cohort of 64 CTEPH patients and in a control group of 25 patients without cardiovascular disease. The biomarker levels were further correlated with clinical, laboratory, and hemodynamic data, including 6-minute walking distance (6-MWD), N-terminal pro-brain natriuretic peptide (NT-proBNP), mean pulmonary artery pressure (meanPAP), pulmonary vascular resistance (PVR), and right atrial pressure (RAP). Results The biomarker levels in the control group were: galectin-3: 3.5 ng/l (IQR 2.7–4.0), GDF-15: 92.6 pg/ml (IQR 78.5–129.1), and ST2: 48.65 ng/l (IQR 35.5–57.0). CTEPH patients had higher levels of GDF-15 (196.7 pg/ml; IQR 128.4–302.8; p<0.001) and ST2 (52.6 ng/l; IQR 44.5–71.9; p=0.05) but not galectin-3 (3.4 ng/l; IQR 2.7–4.3; p=0.84). In the CTEPH cohort, patients with a meanPAP >35 mmHg (GDF-15: p=0.01; ST2: p=0.04) and patients with a PVR >500 dyn sec cm–5 (GDF-15: p=0.004; ST2: p=0.002) had significantly increased biomarker levels. For the detection of a meanPAP >35mmHg, ROC analysis revealed an AUC of 0.71 for GDF-15 and 0.67 for ST2. The level of GDF-15 correlated with the level of NT-proBNP (rrs=0.69; p≤0.001) and the RAP (rrs=0.54; p≤0.001) and inversely with the 6-MWD (rrs=−0.47; p≤0.001). The level of ST2 correlated with the level of NT-proBNP (rrs=0.67; p≤0.001) and the RAP (rrs=0.54; p≤0.001) and inversely with the 6-MWD (rrs=-0.31; p=0.02). Conclusion Our results demonstrate that GDF-15 and ST2, non-invasive biomarkers of myocardial remodelling, are significantly elevated in patients suffering from CTEPH. The correlation of biomarker levels with established outcome predictors suggests a use as indicators of disease severity.

The Forgotten Driving Forces in Right Heart Failure: New Concept and Device

2009 ◽  
Vol 17 (5) ◽  
pp. 525-530 ◽  
Author(s):  
Sayed Nour ◽  
Guifu Wu ◽  
Zheng Zhensheng ◽  
Juan C Chachques ◽  
Alain Carpentier ◽  
...  
Keyword(s):  
Heart Failure ◽  
Right Ventricular ◽  
Driving Forces ◽  
Right Heart Failure ◽  
Experimental Models ◽  
Right Heart ◽  
Assist Device ◽  
Venous Capacitance ◽  
Non Invasive ◽  
The Right

Background: Right heart failure is a frequent hemodynamic disturbance in pediatric cardiac patients. Besides inotropic and chronotropic drugs, fluid administration and inhaled nitric oxide, right ventricular mechanical assistance remains difficult to perform. A circulatory assist device adapted for the right heart biophysics and physiology might be more efficient. Materials and Methods: We are developing a prototype of a non-invasive cardiac assist device (CAD) for neonates and pediatrics. It is based on a pulsatile suit device covering and affecting all territories of the right heart circuit. It will be tested in a neonatal animal model of right ventricular (RV) failure. Experimental models will be matched and compared with control and sham groups. Expected results would be immediate hemodynamic improvement due to synchronized diastolic reduction of stagnant venous capacitance, increasing preload and contractility. On long term, increased shear stress with changing intrathoracic pressure in a phasic way would improve and remodel the pulmonary circulation. Future studies will be focused on: hemodynamic, biochemistry, endothelium function test, and angiogenesis. Comments: A non-invasive CAD guarantees better hemodynamics and endothelial function preservation with low morbidity and mortality. This is a physiological approach, cost-effective method, and particularly interesting in neonates and pediatrics with RV failure.

Organinteraktionen: Herz und Lunge – Management des akuten Rechtsherzversagens

2017 ◽  
Vol 142 (18) ◽  
pp. 1357-1364 ◽  
Author(s):  
Guido Michels ◽  
Roman Pfister
Keyword(s):  
Heart Failure ◽  
Therapy Monitoring ◽  
Right Heart Failure ◽  
Underlying Disease ◽  
Individual Therapy ◽  
Treatment Goals ◽  
Right Heart ◽  
Non Invasive ◽  
The Right ◽  
Focused Echocardiography

AbstractThe pathophysiology and the management of patients with acute right heart failure are very complex. The bed-side focused echocardiography is the basis of differential diagnosis and acute diagnosis. Individual therapy monitoring is complex due to the strong preload dependence of the right ventricle and the limitation of non-invasive estimation of pulmonary-vascular hemodynamics, so that the indication for a pulmonary artery catheter should be liberal in acute right heart failure. The treatment goals of acute right heart failure are the treatment of the underlying disease or triggering factors in combination with individualized optimization of hemodynamic tailored to current right-ventricular function.

276: Non Invasive Measures of Right Heart Hemodynamics Associated with Clinical Improvement Post Heartmate II

2008 ◽  
Vol 27 (2) ◽  
pp. S160
Author(s):  
K.M. Lam ◽  
S. Ennis ◽  
T.E. MacGillivray ◽  
K. Crisalli ◽  
J. Cumuso ◽  
...  
Keyword(s):  
Clinical Improvement ◽  
Right Heart ◽  
Heartmate Ii ◽  
Non Invasive
Sign in / Sign up

Export Citation Format

Share Document